http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008151693-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
| filingDate | 2008-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2008151693-A |
| titleOfInvention | METHOD FOR PREVENTION AND / OR TREATMENT OF DEPENDENCE ON PSYCHOACTIVE SUBSTANCES |
| abstract | 1. A method for the prevention and / or treatment of dependence on psychoactive substances, characterized in that it includes differential diagnosis of the causes of disorders by genetic neurotransmitter metabolism, psychological testing and the appointment of biologically active additives and / or drugs with subsequent monitoring of the psychological state through psychological testing. ! 2. The method according to claim 2, characterized in that the violation of the genetic neurotransmitter metabolism is determined by 1/1 of the dopamine D2 receptor gene, 7 alleles to the dopamine D4 receptor gene, 9/10 dopamine transporter gene, 1/1 dopamine beta-hydroxylase gene. ! 3. The method according to claim 2, characterized in that the violation of the genetic neurotransmitter metabolism is determined by the SS gene of the serotonin carrier, SL gene of the serotonin carrier, s / s gene of the serotonin receptor 2C, c / g gene of the serotonin receptor 2C, 9/10 carrier gene dopamine. ! 4. The method according to claim 2, characterized in that the violation of the genetic neurotransmitter metabolism is determined by the "3-repeat" gene of the monoamine oxidase MAO-A, and / a gene of the monoamine oxidase MAO-B. ! 5. The method according to claim 2, characterized in that the violation of the genetic neurotransmitter metabolism is determined by 9/10 dopamine transporter gene, 2/2 dopamine betahydroxylase gene. ! 6. The method according to claim 2, characterized in that the violation of the genetic neurotransmitter metabolism is determined by 1/1 of the dopamine D2 receptor gene, 7 alleles of the dopamine D4 receptor gene, 9/10 of the dopamine DAT transporter gene, 1/1 of the dopamine beta-hydroxylase gene, g / g serotonin 2C receptor gene, LL serotonin transporter gene. ! 7. The method according to claim 2, characterized in that the violation of geneti |
| priorityDate | 2008-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.